Anthrax LF (Intermediate Domain) Blocking Peptide
- -
- -
Antibody DetailsProduct DetailsReactive Species Bacteria Product Concentration 0.2 mg/ml Amino Acid Location 16 amino acids in the middle of Anthrax lethal factor. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Amino Acid Sequence 16 amino acids in the middle of Anthrax lethal factor. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. Background Anthrax LF peptide is applicable as a control peptide for blocking antibody binding in Western blotting. Antigen DetailsResearch Area Category A Pathogens References & Citations1. Lockshin RA, Osborne B, and Zakeri Z. Cell death in the third millennium. Cell Death Differ. 2000; 7:2-7.
2. Cory S, Huang DCS, and Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22:8590-607.
3. Heiser D, Labi V, Erlacher M, et al. The Bcl-2 protein family and its role in the development of neoplastic disease. Exp. Geron. 2004; 39:1125-35.
4. Wang K, Yin XM, Chao DT, et al. BID: a novel BH3 domain-only death agonist. Genes Dev. 1996; 10:2859-69. |
Related Products
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
